🇺🇸 Isobaric Bupivacaine in United States

7 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Aphasia — 1 report (14.29%)
  2. Dysphagia — 1 report (14.29%)
  3. Foetal Exposure During Pregnancy — 1 report (14.29%)
  4. Foetal Heart Rate Deceleration Abnormality — 1 report (14.29%)
  5. Mood Altered — 1 report (14.29%)
  6. Salivary Hypersecretion — 1 report (14.29%)
  7. Systemic Toxicity — 1 report (14.29%)

Source database →

Isobaric Bupivacaine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Isobaric Bupivacaine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Isobaric Bupivacaine in United States?

Diskapi Yildirim Beyazit Education and Research Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.